通腑汤对急性肺损伤大鼠肺、肠组织CGRP的影响
摘要
目的：观察通腑汤对急性肺损伤大鼠肺与肠组织CGRP水平的影响,探讨通腑汤治疗急性肺损伤的作用机制,从而为通腑汤在临床上的应用提供科学的理论依据。
方法：选取健康Wistar大鼠180只,随机分为6组。即正常对照组、模型组、地塞米松组、中药低剂量组、中药中剂量组、中药高剂量组、30只/组。尾静脉注射LPS复制ALI模型,半小时后中药各剂量组灌胃、地塞米松组腹腔注射治疗,于治疗后第1、2、6小时,每组每次各10只,处死大鼠。光镜下观察肺、肠的组织形态学变化;ELISA法同步检测肺、肠组织中CGRP的含量。
结果：
1、肉眼见模型组肺、肠组织颜色暗红、肿胀、出血、各治疗组较模型组减轻。
2、光镜下见模型组肺、肠组织炎性细胞浸润、水肿、充血、结构破坏,各治疗组较模型组程度减轻。
3、模型组肺、肠组织CGRP含量在前6小时内随时间的延长而增长。
4、ALI肺、肠组织中：模型组CGRP含量高于正常对照组,有统计学意义(P<0.05)；地塞米松组、中药各剂量组CGRP含量均低于模型组,有统计学意义(P<0.05)；中药低剂量组CGRP含量高于地塞米松组,有统计学意义(P<0.05)；中药中剂量组、中药高剂量组CGRP含量与地塞米松组无差异,无统计学意义(P>0.05)；中药中剂量组、中药高剂量组CGRP含量均低于中药低剂量组,有统计学意义(P<0.05)；中药高剂量组CGRP含量与中药中剂量组无差异,无统计学意义(P>0.05)。
结论：
1、通腑汤可降低ALI大鼠肺组织中CGRP的含量,高剂量组与中剂量组疗效较好。
2、通腑汤可降低ALI大鼠肠组织中CGRP的含量,高剂量组与中剂量组疗效较好。
Objective:To observe the effect on CGRP in ALI rat model lung and intestine, and to approach the mechanism of Tongfu Decoction anti-ALI, so to provide experimental base on the lung and the large intestine being interior-exteriorly related theory.
Method:180 healthy wistar rats were choosed and randomly divided into six groups:the normal control group, the model group, hexadecadrol group, Chinese herbal medicine low-dose group, medium-dose group, and high-dose group,30 rats each group. Copying ALI model by caudal vein injecting LPS,giving respectively the Chinese herbal medicine intragastric administration and Dexamethasone intraperitoneal injection half an hour later,and executing rats in 1、2、6 hour after treatment respectively.10 rats each time in each group. We observed lung and intestine histomorphology changes, detected CGRP contene in lung and intestine by ELISA method synchronously.
Result:
1 Lung and intestine tissue in the model group showed dark red, turgent, bleeding by naked eye, but other treatment groups showed lighter than it.
2 Lung and intestine tissue in the model group showed inflammatory cell infiltrate, edema, hyperemia, disorganization in light microscope, but other treatment groups showed lighter.
3 CGRP content increased as time extending in first 6 hours in lung and intestine tissue of the model group.
4 Lung and intestine tissue in ALI:CGRP contents in the model group were higher than the normal control group (P<0.05); contents in hexadecadrol group and Chinese herbal medicine groups were lower than the model group (P<0.05); contents in Chinese herbal medicine low-dose group were higher than hexadecadrol group (P<0.05); contents in Chinese herbal medicine medium-dose group and high-dose group showed lower than low-dose group (P<0.05); Chinese herbal medicine medium-dose group and high-dose group had no statistical significance (p>0.05).
Conclusions:
1 Tongfu Decoction could decrease CGRP in lung tissue of ALI rats model, The curative effects of high-dose and medium-dose group were better.
2 Tongfu Decoction could decrease CGRP in intestine tissue of ALI rats model, The curative effects of high-dose and medium-dose group were better.
方法：选取健康Wistar大鼠180只,随机分为6组。即正常对照组、模型组、地塞米松组、中药低剂量组、中药中剂量组、中药高剂量组、30只/组。尾静脉注射LPS复制ALI模型,半小时后中药各剂量组灌胃、地塞米松组腹腔注射治疗,于治疗后第1、2、6小时,每组每次各10只,处死大鼠。光镜下观察肺、肠的组织形态学变化;ELISA法同步检测肺、肠组织中CGRP的含量。
结果：
1、肉眼见模型组肺、肠组织颜色暗红、肿胀、出血、各治疗组较模型组减轻。
2、光镜下见模型组肺、肠组织炎性细胞浸润、水肿、充血、结构破坏,各治疗组较模型组程度减轻。
3、模型组肺、肠组织CGRP含量在前6小时内随时间的延长而增长。
4、ALI肺、肠组织中：模型组CGRP含量高于正常对照组,有统计学意义(P<0.05)；地塞米松组、中药各剂量组CGRP含量均低于模型组,有统计学意义(P<0.05)；中药低剂量组CGRP含量高于地塞米松组,有统计学意义(P<0.05)；中药中剂量组、中药高剂量组CGRP含量与地塞米松组无差异,无统计学意义(P>0.05)；中药中剂量组、中药高剂量组CGRP含量均低于中药低剂量组,有统计学意义(P<0.05)；中药高剂量组CGRP含量与中药中剂量组无差异,无统计学意义(P>0.05)。
结论：
1、通腑汤可降低ALI大鼠肺组织中CGRP的含量,高剂量组与中剂量组疗效较好。
2、通腑汤可降低ALI大鼠肠组织中CGRP的含量,高剂量组与中剂量组疗效较好。
Objective:To observe the effect on CGRP in ALI rat model lung and intestine, and to approach the mechanism of Tongfu Decoction anti-ALI, so to provide experimental base on the lung and the large intestine being interior-exteriorly related theory.
Method:180 healthy wistar rats were choosed and randomly divided into six groups:the normal control group, the model group, hexadecadrol group, Chinese herbal medicine low-dose group, medium-dose group, and high-dose group,30 rats each group. Copying ALI model by caudal vein injecting LPS,giving respectively the Chinese herbal medicine intragastric administration and Dexamethasone intraperitoneal injection half an hour later,and executing rats in 1、2、6 hour after treatment respectively.10 rats each time in each group. We observed lung and intestine histomorphology changes, detected CGRP contene in lung and intestine by ELISA method synchronously.
Result:
1 Lung and intestine tissue in the model group showed dark red, turgent, bleeding by naked eye, but other treatment groups showed lighter than it.
2 Lung and intestine tissue in the model group showed inflammatory cell infiltrate, edema, hyperemia, disorganization in light microscope, but other treatment groups showed lighter.
3 CGRP content increased as time extending in first 6 hours in lung and intestine tissue of the model group.
4 Lung and intestine tissue in ALI:CGRP contents in the model group were higher than the normal control group (P<0.05); contents in hexadecadrol group and Chinese herbal medicine groups were lower than the model group (P<0.05); contents in Chinese herbal medicine low-dose group were higher than hexadecadrol group (P<0.05); contents in Chinese herbal medicine medium-dose group and high-dose group showed lower than low-dose group (P<0.05); Chinese herbal medicine medium-dose group and high-dose group had no statistical significance (p>0.05).
Conclusions:
1 Tongfu Decoction could decrease CGRP in lung tissue of ALI rats model, The curative effects of high-dose and medium-dose group were better.
2 Tongfu Decoction could decrease CGRP in intestine tissue of ALI rats model, The curative effects of high-dose and medium-dose group were better.
引文
[1]Ashbaugh DG,Bigelow DB,Petty TL,et al.Acute respiratory distress in adults[J].Lan cet,1967,2(1):319-323.
[2]Marshall RP,Webb S,HillMR,et al.Genetic polymorphisms associated with suscep tibility and outcome in ARDS[J].Chest,2002,121(3 Suppl):685-695.
[3]耿耘,马超英.中西医结合治疗呼吸窘迫综合征临床观察.江西中医学院学报,1997,9(1)：3.
[4]马超英,耿耘,彭仁才,等.加减陷胸桃承汤合参脉针抗大鼠腹腔感染所致肺损伤实验观察.中医杂志,2000；41(11)：683-685.
[5]耿耘,马超英,程琳慧,等.加减陷胸桃承汤合参脉针防治油酸型ARDS动物的实验观察.中国医药学报,2000；15(3)：24.
[6]薛芳.急性呼吸窘迫综合征和阳明腑实喘满证.辽宁中医杂志,1982；9(4)：10-11.
[7]薛芳.大承气汤治疗家兔呼吸窘迫综合征的研究.中西医结台杂志,1988；8(5)：285.
[8]阎田玉,龚明敏,林胡春,等.活血化疲治疗小儿病毒性肺炎的机理探讨与电观察.中西医结合杂志,1984；4(3)：139-142.
[9]熊磊.急性呼吸窘迫综合征中医认识概况.云南中医学院学报,1991；14(3)：1-4,14.
[10]李明富.中医对呼吸窘迫综合征的认识.成都中医学院学报,1980；3(1)：3-6.
[11]李金波,周立群.针刺治疗脑水肿继发ARDS 20例临床报告.中国针灸,1992；11(5)：27.
[12]王今达,崔乃杰,等.清心泻肝法治疗急性呼吸窘迫综合征22例临床观察.中国中西医结合急救杂志,1997；4(10)：453.
[13]叶汉兰,潘可欣.中西医结合治疗成人呼吸窘迫综合症20例.北京中医药大学学报,1998：21(1)：48-49.
[14]金星,郑丰杰.急性肺损伤中医学发病机制及治疗思路探讨[J].中医药临床杂志2008 20(1)76-77.
[15]钱桂生.急性肺损伤和急性呼吸窘迫综合征研究进展[J].重庆医学,2002,31(9)：769-771.
[16]李春盛,桂培春,何新华,等.大黄对内毒素诱导急性肺损伤大鼠的保护作用、基础医学与临床,2001,21(1)：65-68.
[17]杨光,李鸣真,黄光英,等.热毒清对家兔内毒素性急性肺损伤的保护作用中国中 西医结合外科杂志,1996,(6)：455-459.
[18]杨明炜,陆付耳,李鸣真,等.热毒清对内毒素体内、外诱生肿瘤坏死因子的影响.中国中医基础医学杂志,2000,6(8)：547-548.
[19]马超英,夏红梅,耿耘.加减陷胸桃承汤合参麦注射液对急性呼吸窘迫综合征大鼠细胞凋亡的影响[J].中国中西医结合急救杂志,2006,13(4)：195.
[20]刘慧卿,李志文.双黄灌肠液治疗急性肺损伤疗效观察[J].中国中医急症,2006,5：467.
[21]刘松,俞森洋,刘庆辉,等.丹参对偏二甲基肼和四氧化二氮吸入性肺损伤的作用[J].中华急诊医学杂志,2006,15(2)：136.
[22]黄念秋,宋惠芳,汪建新,等.内毒素致家兔急性肺损伤时肺和肺外脏器的病理组织学变化及东莨菪碱和前列腺素E1的保护作用[J].中国危重病急救医学,1997,9(6)：326.
[23]丁慧芬.中医肺与急性肺损伤的发病关系初探[J].辽宁中医杂志,2004,31(10)：823.
[24]王今达.如何探寻防治急性呼吸窘迫综合征的新策略[J].中国危重病急救医学,1997,9(1)：1.
[25]黄翠萍,杨和平,张珍祥.参麦注射液对脂多糖诱导大鼠急性肺损伤防护机制探讨[J].中华结核和呼吸杂志,2005,28(1)：67.
[26]顾俭勇,黄培志.黄芪对脂多糖致急性肺损伤的保护机制[J].中国临床医学,2005,12(6)：1147.
[27]艾宇航,彭鎏,张丽娜.参附注射液对内毒素所致肺损伤的保护作用[J].中国急救医学,2006,26(4)：85.
[28]刘小虹,廖慧丽.补肾祛邪法治疗哮喘的临床研究[J].中医药学刊,2002,20(5)：697-700.
[29]肖光华,吴敏,宓越群,等.喘可治对急性肺损伤大鼠干预作用的研究[J].上海交通大学学报(医学版),2008,28(10)：831-833.
[30]Bernard GR,Artigs A,Brigham KL,et al.The American2European Consensus Confe rence on ARDS:definitions,mechanisms,relevant outcomes,and clinical trial cordinatio n[J].Am J Respir Crit Care Med,1994,148(3 Pt 1):818-824.
[31]MacCallum NS,Evans TW.Ep idemiology of acute lung injury[J].CurrOp in Crit Care,2005,11(1):43-49.
[32]Me Intyre RC, Piilido EJ,Bensard DD,et al. Thirty years of clinical trials in acute respiratory distress syndrome [J].Crit Care Med,2000,28(9):3314-3331.
[33]Lu YM,Song ZF,Zhou X,et al.A 122month clinical survey of incidence and outcom e of acute respiratory syndrome in Shanghai intensive care unit[J].Intensive Care Med, 2004,30(12):2197-2230.
[34]HerridgeMS,CheungAM,Tansey CM,et al.The Canadian Critical Care Clinical trials group.One year outcomes of the survivors of the acute respiratory distress syndrome[J].N Engl J Med,2003,348(8):683-693.
[35]Jroliga AC,Ghamra ZW,Perez TA,etal.Incidence of ARDS in an adult Population of northeast Ohio.Chest.2002.121 (6):1972-6.
[36]Bersten AD,Edibam C,Hullt T,MoranJ.Incidence and mortality of acute lung injury and the acute respiratory distress Syndrome in three Australian States.Am[J] ResPir Crit Care Med,2002.165(4):443-8.
[37]Angus DC,Linde-Zwirble WT,Lidieker J,Clermonit G,Careillo J,Pinsky MR. Epidemiology of severe sepsis in the United States:analysis of incidence outcome,and associated cost of care.Crit Care Med.2001.29(7):1303-10.
[38]Johnston CJ,Rubenfeld GD.Hudson LD Effect of age on the development of ARD in trauma patients.Chest Peetivestudy.Burns.2002.28(3):245-9.2003.124(2):653-9.
[39]Chen XL,wang YJ,Wang CR Hu DL,Sun YX,Liss.Burns due to gun Powder Explosi on fire works factory:a 13-year retrospective Pective study Burns.2002.28(3):245-9.
[40]Shorr AF,Abbott KC,Agadoal LY.Acute respiratory distress syndrome after kidney ransplantation:epidemiology,risk factors,and outcomes.Crit Care Med.2003.31 (5):13 25-30.
[41].SillimanCC,BoshkovLK,MehdizadehkashiZ,etal.Transfusion-related acute Lung injury:epidemiology and apropective analysis of etiologic factors. Blood 2003.101(2): 454-62.
[42]Silliman CC,Ambruso DR,Boshkov LK. Transfusion-related acute lung injury Blood.2005.105(6):2266-73.
[43]Wbert KE,Blajhman MA.Transfusion-related acute lung injury Curr Opin Hematol. 2005.12(6):480-7.
[44]SillimanCC,Boshkov LK,Mehdizadehkashi Z,et al. Transfusion-related acute Lung injury epidemiology and aprospective analysis of etiologic factors Blood.2003.101(2): 454-62.
[45]LewTW,KWek TK,Tai D, et al. Acute respiratory distress syndrome in critically ill Patients with severe acute respiratory syndrome.JAMA.2003.290(3):374-80.
[46]Goodnlan RB,Pugin J,Lee JS,Matthay MA.Cytokine-mediated inflammation in Acute lung injury.Cytokine Growth Factor Rev.2003.14(6):523-35.
[47]Matthay MA.The acute respiratory distress syndrome.N Engl JMed.1996.334 (22): 1469-70.
[48]Imalnura S,Matsukawa A,Ohkawara S,Kagayama M,Yoshinaga M.Involvement of tumor necrosis factor-alpha,interleukin-1 beta,interleukin-8,and inierleukin-1 receptor antagonist in acute lung injury caused by local Shwartzman reaction.Pathol Int.1997.47 (1):16-24.
[49]PuginJ,Ricou B,Steinberg KP,Suter PM,Martin TR.Proin flammatory activity In bronehoalveolar lavage fluids from patients with ARDS, a Prominent role for interlerkin-1 Am J Respir Crit Care Med.1996.153(6 Pt 1):1850-6.
[50]Shanley TP,Vasi N,Denenberg A.Regulation of chemokine expression by IL-10In lung inflammation.Cytokine.2000.12(7):1054-64.
[51]Park WY,Goodman RB,Steinberg KP,et al.Cytokine balance in the lungs of Patients with acute respiratory distress Syndrome.Am J Respir Crit Care Med. 2001.164(10 Pt 1):1896-903.
[52]Marshall RP,Bellingan G,Webb S,et al.Fibro proliferation occurs Early in the acute respiratory distresss syndrome and impacts on outcome Am J Respir Crit Care Med,2000; 162(5):1783-1788.
[53]Gattinoni L,Bombino M,Pelosi P,et al.Lung structure and function at different stages of severe adult respiratory distress syndrome[J].JAMA,1994,271(22):1772-1779.
[54]Matthay MA,Ware LB.Plasma protein C levels in patients with acute lung injury:p-rognostic significance[J].Crit Care Med,2004,32(5 Supp 1):S229-S232.
[55]Esteban A,Anzueto A,Frutos F, et al.Characteristics and outcomes in adult patients receiving mechanical ventilation:a 28 day international study[J].JAMA,2002,287(3): 345-355.
[56]Gattinoni L,Presenti A,Bombino M,et al. Relationships between lung CT density, gas exchange, and PEEP in acute respiratory failure[J].Anesthesiology,1998,69(4) 824-832.
[57]TremblayL,Valenza F, Riberio SP, et al. Injurious ventilation strategies increase cytokines and c-fosm-RNA expression in an isolated rat lung model[J]. J Clin Invest,1997,99(5):944-952.
[58]ARDS Network.Ventilation with lower tidal volumes as compared to traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome [J].N Engl J Med,2000,342(18):1301-1308.
[59]Brower RG,Morris AH,Maclntyre N,et al.Effects of recruitment maneuvers in patients with acute lung injury and acute respiratory distress syndrome ventilated with high end expiratory pressure[J].Crit Care Med,2003,31(11):2592-2597.
[60]Montgomery AB,Stager MA,Carrico CJ,et al.Causes of mortality in patients with the adult respiratory distress syndrome [J].Am Rev Respir Dis,1985,132 (3):485-489.
[61]Morris AH, Wallace CJ,Menlove RI, et.al.Randomized clinical trial of pressure controlled inverse ratio ventilation and extracorporeal CCX removal for acute respirat ory distress syndrome[J].Am J Respir Crit Care Med,1994,149(2 Pt 1):295-305.
[62]Hill JC,Maske R.Pathogenesis of pterygium [J].Eye,1989,(3 Pt 2):218-226.
[63]Fukushima S,Inoue T,Inoue T,et al.Postoperative irradiation ofpterygium with 90Sr eye applicator[J].Int J Radiat Ohcol Biol Phy,1999,43(3):597-600.
[64]姚咏明MODS抗炎治疗的反思.中国危重病急救医学,1999；11(8)：456-458.
[65]陆付耳,李鸣真,叶望云.论内毒素血症的治疗对策.中国危重病急救医学,2000,12(10)：579-580.
[66]陆峰.急性呼吸窘迫综合征炎症反应机制与中西医结合免疫调理治疗的探讨.中国中西医结合杂志,2002；22(6)：473-477.
[67]南医学院.生理学[M].北京：人民卫生出版社,1978.374.
[68]匡调元.中医病理研究[M].上海：上海科学技术出版社1980.140.
[69]钟学礼,池芝盛,陈家伦,等.中国医学百科全书[M].上海：上海科学技术出版 社,1986.128.
[70]杨钢.人体内分泌生理及异常[M].天津：天津科学技术出版社,1980.474.
[71]耿耘,魏星.急性呼吸窘迫综合征的中医发病机理探讨[J].江西中医药,2002,33(5)：11-12.
[72]Rosenfeld MG.Production of a novel neuropeptide encoded by the calcitonin gene via tissue specific RNA processing[J].Nature.1983,304:129.
[73]路长林.神经肽基础与临床[M].第1版.上海：第二军医大学出版社.2000,192.
[74]Shimesegawa T,Said SI.Pulmonary calcitonin gene-related peptide immunoreactivi ty nerve-endocrine cell interrelationships[J].Am J Respir Cell Mol Biol,1994,4(2):126.
[75]Keith IM,Pelto-Huikko M,Schalling M,et al.Calcitonin gene-related peptide and its mRNA in pulmonary neuroendocring cells and ganglia[J].Histochemistry,1991, 96(4):311.
[76]Alfons TL,Lommel v,Lauweryns JM.Ultrastructure and innervation of neuroc pithelial bodies in the lungs of newborn cats[J].Anat Rec.1993,236(1):201.
[77]Cutz E.Jackson A.Neurocpithelial bodies as airway oxygen sensors[J].Respir Physiol.1999,115(2):201.
[78]Stahlman MT,Gray ME,Immunogold EM localization of neurochemicals in human pulmonary neuroehdocrine cell[J].Micro Res Tceh,1997.37(1):77.
[79]Stahlman MT,Gray ME.Colocalization of peptide hormones in neuroendocrine cells of human fetal and newborn lungs:an electron microscopic study[J].Anat Rec.1993,236(1):206.
[80]Peter Baluk,Jay A,Nadel,and Donald M.McDonald.calcitonin gene-related peptide in secretory granules of serous cells in the rat tracheal epithdium.Am[J].J.Respir.Cell Mol.Biol,1993,(8):446.
[81]Randolph H Hastings and Xiao-ying Hua Expression of calcitonin gene-relate peptide by cultured rat albeolar type Ⅱ cells [J] Am,J.Respir,Cell Mol,Biol,1995.(13) :563
[82]Conner.Ac,Hay DL,Howitt SG,et al.Interaction of CGRP with its receptor[J], Biohem Soc Trans,2002.30(4):451.
[83]Njuki F.Nicholl CG,Howard A,et al.A new ealcitonin-receptor-like sequence in rat pulmonary blood vessels[J].Clin sei(Lond),1993,85:385.
[84]Fluhmann B.Muff R.Hunziker W,et al.A human orphan calcitonin receptor-like structure[J].Biohem Biophys Res Commun,1995,206:341.
[85]Preibisz JJ.Calcitonin gene-related peptide and regulation of human car Dio-vascu lar homeostasis[J].Am J Hypertens.1993,6(5 Pt 1):434.
[86]Takahashi Y,De Vroomen M,Rowan C et al.Mechanisms of CGRP-induced increas es of pulmonary bood flow in fetal sheep[J].Am J Physiol Heart Circ Physiol,2000.279 (4):H1654.
[87]Ninomiya H,Uchida Y,Roman C Endo T,et al.The effects of CGRP on tracheal smooth muscle of guimea-pigs in vitro[J].Br J Phamacol,1996.119(7):1341.
[2]Marshall RP,Webb S,HillMR,et al.Genetic polymorphisms associated with suscep tibility and outcome in ARDS[J].Chest,2002,121(3 Suppl):685-695.
[3]耿耘,马超英.中西医结合治疗呼吸窘迫综合征临床观察.江西中医学院学报,1997,9(1)：3.
[4]马超英,耿耘,彭仁才,等.加减陷胸桃承汤合参脉针抗大鼠腹腔感染所致肺损伤实验观察.中医杂志,2000；41(11)：683-685.
[5]耿耘,马超英,程琳慧,等.加减陷胸桃承汤合参脉针防治油酸型ARDS动物的实验观察.中国医药学报,2000；15(3)：24.
[6]薛芳.急性呼吸窘迫综合征和阳明腑实喘满证.辽宁中医杂志,1982；9(4)：10-11.
[7]薛芳.大承气汤治疗家兔呼吸窘迫综合征的研究.中西医结台杂志,1988；8(5)：285.
[8]阎田玉,龚明敏,林胡春,等.活血化疲治疗小儿病毒性肺炎的机理探讨与电观察.中西医结合杂志,1984；4(3)：139-142.
[9]熊磊.急性呼吸窘迫综合征中医认识概况.云南中医学院学报,1991；14(3)：1-4,14.
[10]李明富.中医对呼吸窘迫综合征的认识.成都中医学院学报,1980；3(1)：3-6.
[11]李金波,周立群.针刺治疗脑水肿继发ARDS 20例临床报告.中国针灸,1992；11(5)：27.
[12]王今达,崔乃杰,等.清心泻肝法治疗急性呼吸窘迫综合征22例临床观察.中国中西医结合急救杂志,1997；4(10)：453.
[13]叶汉兰,潘可欣.中西医结合治疗成人呼吸窘迫综合症20例.北京中医药大学学报,1998：21(1)：48-49.
[14]金星,郑丰杰.急性肺损伤中医学发病机制及治疗思路探讨[J].中医药临床杂志2008 20(1)76-77.
[15]钱桂生.急性肺损伤和急性呼吸窘迫综合征研究进展[J].重庆医学,2002,31(9)：769-771.
[16]李春盛,桂培春,何新华,等.大黄对内毒素诱导急性肺损伤大鼠的保护作用、基础医学与临床,2001,21(1)：65-68.
[17]杨光,李鸣真,黄光英,等.热毒清对家兔内毒素性急性肺损伤的保护作用中国中 西医结合外科杂志,1996,(6)：455-459.
[18]杨明炜,陆付耳,李鸣真,等.热毒清对内毒素体内、外诱生肿瘤坏死因子的影响.中国中医基础医学杂志,2000,6(8)：547-548.
[19]马超英,夏红梅,耿耘.加减陷胸桃承汤合参麦注射液对急性呼吸窘迫综合征大鼠细胞凋亡的影响[J].中国中西医结合急救杂志,2006,13(4)：195.
[20]刘慧卿,李志文.双黄灌肠液治疗急性肺损伤疗效观察[J].中国中医急症,2006,5：467.
[21]刘松,俞森洋,刘庆辉,等.丹参对偏二甲基肼和四氧化二氮吸入性肺损伤的作用[J].中华急诊医学杂志,2006,15(2)：136.
[22]黄念秋,宋惠芳,汪建新,等.内毒素致家兔急性肺损伤时肺和肺外脏器的病理组织学变化及东莨菪碱和前列腺素E1的保护作用[J].中国危重病急救医学,1997,9(6)：326.
[23]丁慧芬.中医肺与急性肺损伤的发病关系初探[J].辽宁中医杂志,2004,31(10)：823.
[24]王今达.如何探寻防治急性呼吸窘迫综合征的新策略[J].中国危重病急救医学,1997,9(1)：1.
[25]黄翠萍,杨和平,张珍祥.参麦注射液对脂多糖诱导大鼠急性肺损伤防护机制探讨[J].中华结核和呼吸杂志,2005,28(1)：67.
[26]顾俭勇,黄培志.黄芪对脂多糖致急性肺损伤的保护机制[J].中国临床医学,2005,12(6)：1147.
[27]艾宇航,彭鎏,张丽娜.参附注射液对内毒素所致肺损伤的保护作用[J].中国急救医学,2006,26(4)：85.
[28]刘小虹,廖慧丽.补肾祛邪法治疗哮喘的临床研究[J].中医药学刊,2002,20(5)：697-700.
[29]肖光华,吴敏,宓越群,等.喘可治对急性肺损伤大鼠干预作用的研究[J].上海交通大学学报(医学版),2008,28(10)：831-833.
[30]Bernard GR,Artigs A,Brigham KL,et al.The American2European Consensus Confe rence on ARDS:definitions,mechanisms,relevant outcomes,and clinical trial cordinatio n[J].Am J Respir Crit Care Med,1994,148(3 Pt 1):818-824.
[31]MacCallum NS,Evans TW.Ep idemiology of acute lung injury[J].CurrOp in Crit Care,2005,11(1):43-49.
[32]Me Intyre RC, Piilido EJ,Bensard DD,et al. Thirty years of clinical trials in acute respiratory distress syndrome [J].Crit Care Med,2000,28(9):3314-3331.
[33]Lu YM,Song ZF,Zhou X,et al.A 122month clinical survey of incidence and outcom e of acute respiratory syndrome in Shanghai intensive care unit[J].Intensive Care Med, 2004,30(12):2197-2230.
[34]HerridgeMS,CheungAM,Tansey CM,et al.The Canadian Critical Care Clinical trials group.One year outcomes of the survivors of the acute respiratory distress syndrome[J].N Engl J Med,2003,348(8):683-693.
[35]Jroliga AC,Ghamra ZW,Perez TA,etal.Incidence of ARDS in an adult Population of northeast Ohio.Chest.2002.121 (6):1972-6.
[36]Bersten AD,Edibam C,Hullt T,MoranJ.Incidence and mortality of acute lung injury and the acute respiratory distress Syndrome in three Australian States.Am[J] ResPir Crit Care Med,2002.165(4):443-8.
[37]Angus DC,Linde-Zwirble WT,Lidieker J,Clermonit G,Careillo J,Pinsky MR. Epidemiology of severe sepsis in the United States:analysis of incidence outcome,and associated cost of care.Crit Care Med.2001.29(7):1303-10.
[38]Johnston CJ,Rubenfeld GD.Hudson LD Effect of age on the development of ARD in trauma patients.Chest Peetivestudy.Burns.2002.28(3):245-9.2003.124(2):653-9.
[39]Chen XL,wang YJ,Wang CR Hu DL,Sun YX,Liss.Burns due to gun Powder Explosi on fire works factory:a 13-year retrospective Pective study Burns.2002.28(3):245-9.
[40]Shorr AF,Abbott KC,Agadoal LY.Acute respiratory distress syndrome after kidney ransplantation:epidemiology,risk factors,and outcomes.Crit Care Med.2003.31 (5):13 25-30.
[41].SillimanCC,BoshkovLK,MehdizadehkashiZ,etal.Transfusion-related acute Lung injury:epidemiology and apropective analysis of etiologic factors. Blood 2003.101(2): 454-62.
[42]Silliman CC,Ambruso DR,Boshkov LK. Transfusion-related acute lung injury Blood.2005.105(6):2266-73.
[43]Wbert KE,Blajhman MA.Transfusion-related acute lung injury Curr Opin Hematol. 2005.12(6):480-7.
[44]SillimanCC,Boshkov LK,Mehdizadehkashi Z,et al. Transfusion-related acute Lung injury epidemiology and aprospective analysis of etiologic factors Blood.2003.101(2): 454-62.
[45]LewTW,KWek TK,Tai D, et al. Acute respiratory distress syndrome in critically ill Patients with severe acute respiratory syndrome.JAMA.2003.290(3):374-80.
[46]Goodnlan RB,Pugin J,Lee JS,Matthay MA.Cytokine-mediated inflammation in Acute lung injury.Cytokine Growth Factor Rev.2003.14(6):523-35.
[47]Matthay MA.The acute respiratory distress syndrome.N Engl JMed.1996.334 (22): 1469-70.
[48]Imalnura S,Matsukawa A,Ohkawara S,Kagayama M,Yoshinaga M.Involvement of tumor necrosis factor-alpha,interleukin-1 beta,interleukin-8,and inierleukin-1 receptor antagonist in acute lung injury caused by local Shwartzman reaction.Pathol Int.1997.47 (1):16-24.
[49]PuginJ,Ricou B,Steinberg KP,Suter PM,Martin TR.Proin flammatory activity In bronehoalveolar lavage fluids from patients with ARDS, a Prominent role for interlerkin-1 Am J Respir Crit Care Med.1996.153(6 Pt 1):1850-6.
[50]Shanley TP,Vasi N,Denenberg A.Regulation of chemokine expression by IL-10In lung inflammation.Cytokine.2000.12(7):1054-64.
[51]Park WY,Goodman RB,Steinberg KP,et al.Cytokine balance in the lungs of Patients with acute respiratory distress Syndrome.Am J Respir Crit Care Med. 2001.164(10 Pt 1):1896-903.
[52]Marshall RP,Bellingan G,Webb S,et al.Fibro proliferation occurs Early in the acute respiratory distresss syndrome and impacts on outcome Am J Respir Crit Care Med,2000; 162(5):1783-1788.
[53]Gattinoni L,Bombino M,Pelosi P,et al.Lung structure and function at different stages of severe adult respiratory distress syndrome[J].JAMA,1994,271(22):1772-1779.
[54]Matthay MA,Ware LB.Plasma protein C levels in patients with acute lung injury:p-rognostic significance[J].Crit Care Med,2004,32(5 Supp 1):S229-S232.
[55]Esteban A,Anzueto A,Frutos F, et al.Characteristics and outcomes in adult patients receiving mechanical ventilation:a 28 day international study[J].JAMA,2002,287(3): 345-355.
[56]Gattinoni L,Presenti A,Bombino M,et al. Relationships between lung CT density, gas exchange, and PEEP in acute respiratory failure[J].Anesthesiology,1998,69(4) 824-832.
[57]TremblayL,Valenza F, Riberio SP, et al. Injurious ventilation strategies increase cytokines and c-fosm-RNA expression in an isolated rat lung model[J]. J Clin Invest,1997,99(5):944-952.
[58]ARDS Network.Ventilation with lower tidal volumes as compared to traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome [J].N Engl J Med,2000,342(18):1301-1308.
[59]Brower RG,Morris AH,Maclntyre N,et al.Effects of recruitment maneuvers in patients with acute lung injury and acute respiratory distress syndrome ventilated with high end expiratory pressure[J].Crit Care Med,2003,31(11):2592-2597.
[60]Montgomery AB,Stager MA,Carrico CJ,et al.Causes of mortality in patients with the adult respiratory distress syndrome [J].Am Rev Respir Dis,1985,132 (3):485-489.
[61]Morris AH, Wallace CJ,Menlove RI, et.al.Randomized clinical trial of pressure controlled inverse ratio ventilation and extracorporeal CCX removal for acute respirat ory distress syndrome[J].Am J Respir Crit Care Med,1994,149(2 Pt 1):295-305.
[62]Hill JC,Maske R.Pathogenesis of pterygium [J].Eye,1989,(3 Pt 2):218-226.
[63]Fukushima S,Inoue T,Inoue T,et al.Postoperative irradiation ofpterygium with 90Sr eye applicator[J].Int J Radiat Ohcol Biol Phy,1999,43(3):597-600.
[64]姚咏明MODS抗炎治疗的反思.中国危重病急救医学,1999；11(8)：456-458.
[65]陆付耳,李鸣真,叶望云.论内毒素血症的治疗对策.中国危重病急救医学,2000,12(10)：579-580.
[66]陆峰.急性呼吸窘迫综合征炎症反应机制与中西医结合免疫调理治疗的探讨.中国中西医结合杂志,2002；22(6)：473-477.
[67]南医学院.生理学[M].北京：人民卫生出版社,1978.374.
[68]匡调元.中医病理研究[M].上海：上海科学技术出版社1980.140.
[69]钟学礼,池芝盛,陈家伦,等.中国医学百科全书[M].上海：上海科学技术出版 社,1986.128.
[70]杨钢.人体内分泌生理及异常[M].天津：天津科学技术出版社,1980.474.
[71]耿耘,魏星.急性呼吸窘迫综合征的中医发病机理探讨[J].江西中医药,2002,33(5)：11-12.
[72]Rosenfeld MG.Production of a novel neuropeptide encoded by the calcitonin gene via tissue specific RNA processing[J].Nature.1983,304:129.
[73]路长林.神经肽基础与临床[M].第1版.上海：第二军医大学出版社.2000,192.
[74]Shimesegawa T,Said SI.Pulmonary calcitonin gene-related peptide immunoreactivi ty nerve-endocrine cell interrelationships[J].Am J Respir Cell Mol Biol,1994,4(2):126.
[75]Keith IM,Pelto-Huikko M,Schalling M,et al.Calcitonin gene-related peptide and its mRNA in pulmonary neuroendocring cells and ganglia[J].Histochemistry,1991, 96(4):311.
[76]Alfons TL,Lommel v,Lauweryns JM.Ultrastructure and innervation of neuroc pithelial bodies in the lungs of newborn cats[J].Anat Rec.1993,236(1):201.
[77]Cutz E.Jackson A.Neurocpithelial bodies as airway oxygen sensors[J].Respir Physiol.1999,115(2):201.
[78]Stahlman MT,Gray ME,Immunogold EM localization of neurochemicals in human pulmonary neuroehdocrine cell[J].Micro Res Tceh,1997.37(1):77.
[79]Stahlman MT,Gray ME.Colocalization of peptide hormones in neuroendocrine cells of human fetal and newborn lungs:an electron microscopic study[J].Anat Rec.1993,236(1):206.
[80]Peter Baluk,Jay A,Nadel,and Donald M.McDonald.calcitonin gene-related peptide in secretory granules of serous cells in the rat tracheal epithdium.Am[J].J.Respir.Cell Mol.Biol,1993,(8):446.
[81]Randolph H Hastings and Xiao-ying Hua Expression of calcitonin gene-relate peptide by cultured rat albeolar type Ⅱ cells [J] Am,J.Respir,Cell Mol,Biol,1995.(13) :563
[82]Conner.Ac,Hay DL,Howitt SG,et al.Interaction of CGRP with its receptor[J], Biohem Soc Trans,2002.30(4):451.
[83]Njuki F.Nicholl CG,Howard A,et al.A new ealcitonin-receptor-like sequence in rat pulmonary blood vessels[J].Clin sei(Lond),1993,85:385.
[84]Fluhmann B.Muff R.Hunziker W,et al.A human orphan calcitonin receptor-like structure[J].Biohem Biophys Res Commun,1995,206:341.
[85]Preibisz JJ.Calcitonin gene-related peptide and regulation of human car Dio-vascu lar homeostasis[J].Am J Hypertens.1993,6(5 Pt 1):434.
[86]Takahashi Y,De Vroomen M,Rowan C et al.Mechanisms of CGRP-induced increas es of pulmonary bood flow in fetal sheep[J].Am J Physiol Heart Circ Physiol,2000.279 (4):H1654.
[87]Ninomiya H,Uchida Y,Roman C Endo T,et al.The effects of CGRP on tracheal smooth muscle of guimea-pigs in vitro[J].Br J Phamacol,1996.119(7):1341.